Developments of DNA-dependent Protein Kinase Inhibitors as Anticancer Agents

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|14|11|884-895

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.14, Iss.11, 2014-10, pp. : 884-895

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclin-dependent kinase inhibitors: novel anticancer agents

By Mani S.   Wang C.   Wu K.   Francis R.   Pestell R.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 8, 2000-08 ,pp. : 1849-1870

Informa Healthcare

Access to resources Recommend Favorite

Protein tyrosine kinase inhibitors as anticancer agents

By Supuran Claudiu T   Scozzafava Andrea  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 1, 2004-01 ,pp. : 35-53

Informa Healthcare

Access to resources Recommend Favorite

Perspectives of Protein Kinase C (PKC) Inhibitors as Anti-Cancer Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 4, 2009-04 ,pp. : 498-509

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments of DNA Poisons - Human DNA Topoisomerase II Inhibitors - as Anticancer Agents

By  

Current Pharmaceutical Design, Vol. 19, Iss. 13, 2013-04 ,pp. : 2474-2488

Bentham Science Publishers

Access to resources Recommend Favorite

Developments of Polo-like Kinase 1 (Plk1) Inhibitors as Anti-Cancer Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 14, 2013-12 ,pp. : 2014-2025

Bentham Science Publishers

Access to resources Recommend Favorite